UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 1, 2017

 

 

VERISK ANALYTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		001-34480		26-2994223
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)
545 Washington Boulevard, Jersey City, NJ				07310
(Address of principal executive offices)				(Zip Code)

Registrant’s telephone number, including area code: (201) 469-2000

 

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Effective January 1, 2017, Verisk Analytics, Inc. (the “Company”) designated Glenn A. McConnell as the Company’s Principal Accounting Officer. Mr. McConnell will also continue to serve in his current role as Senior Vice President and Controller.

Mr. McConnell, age 54, joined the Company’s Insurance Services Office subsidiary in 2001 as assistant controller. He was instrumental in assisting with the Company’s initial public offering in 2009 and has directed the accounting diligence on a number of major acquisitions. Before joining the Company, Mr. McConnell was controller of Innovex (a division of Quintiles Transnational Corp.), Pharmaceutical Resources, Inc., and Richard A. Eisner & Company.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

						VERISK ANALYTICS, INC.
Date: January 6, 2017						By:		/s/ Kenneth E. Thompson
								Name:		Kenneth E. Thompson
								Title:		Executive Vice President, General Counsel and Corporate Secretary